Predictive Genetic Testing for Alzheimer's Disease in Long-Term Care Insurance

28 Pages Posted: 5 Feb 2010

Date Written: February 1, 2001

Abstract

The promise of new genetic research is the ability to prevent, treat, and cure a wide range of physical and mental disorders - both monogenic and complex disorders. While astonshing progress has been made in gene discovery and development of genetic tests, progress has been much slower in developing medicial interventions. Consequently, there is likely a gap of varing and indeterminante time - lasting years or even decades - between the ability to identify and predict genetic risk and the ability to prevent, treat, or cure the condition.

Keywords: privacy, confidentiality, genetics, genetic discrimination, genetic research, biobanks, pharmacogenomics, genetic information

JEL Classification: K31, K32

Suggested Citation

Rothstein, Mark A., Predictive Genetic Testing for Alzheimer's Disease in Long-Term Care Insurance (February 1, 2001). Georgia Law Review, Vol. 35, No. 2, p. 707, 2001, Available at SSRN: https://ssrn.com/abstract=1547280

Mark A. Rothstein (Contact Author)

U of Louisville ( email )

3787 Via Vuelta
3787 Via Vuelta
Rancho Santa Fe, CA 92091
United States
15025299381 (Phone)

Do you have negative results from your research you’d like to share?

Paper statistics

Downloads
111
Abstract Views
1,732
Rank
444,918
PlumX Metrics